Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progression - Wikidata - awgldk - TriplyDB

Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progression

Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progression

http://www.wikidata.org/entity/Q34077384

about

Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials EEF1A2 inactivates p53 by way of PI3K/AKT/mTOR-dependent stabilization of MDM4 in hepatocellular carcinoma.Differentiation of stem cells upon deprivation of exogenous FGF2: a general approach to study spontaneous differentiation of hESCs in vitro.Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.Tumor suppressor p16(INK4a) inhibits cancer cell growth by downregulating eEF1A2 through a direct interaction.Identification of molecular tumor markers in renal cell carcinomas with TFE3 protein expression by RNA sequencing.Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression.Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer.Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals.The more basic isoform of eEF1A relates to tumour cell phenotype and is modulated by hyper-proliferative/differentiating stimuli in normal lymphocytes and CCRF-CEM T-lymphoblasts.Potential Applications of Nanocellulose-Containing Materials in the Biomedical Field.The EEF1A2 gene expression as risk predictor in localized prostate cancer.Mammalian translation elongation factor eEF1A2: X-ray structure and new features of GDP/GTP exchange mechanism in higher eukaryotes.The expression profile and prognostic significance of eukaryotic translation elongation factors in different cancers.Systematic tracking of dysregulated modules identifies novel genes in cancer.eEF1A2 promotes cell migration, invasion and metastasis in pancreatic cancer by upregulating MMP-9 expression through Akt activation.[EEF1A2 inhibits the p53 function in hepatocellular carcinoma via PI3K/AKT/mTOR-dependent stabilization of MDM4].

P2860

Q26824909-7BEA2481-6C32-4CBE-8511-44A44C1A434C Q33970628-A126B986-3048-41CB-B133-A59D8E35797E Q36425858-CB1D88D4-03C2-4DFA-BD7F-8CFEDD630884 Q36782329-2C85EB9D-4FC9-4F9E-9D62-869D7840ECAC Q36815029-D7F82377-9C09-41B2-B4CA-DBE30EADF897 Q36918294-394AE3E1-3194-4214-A296-E66B57A9127D Q37384169-7AE24218-4298-4FD7-AD01-D4B9EA3FD207 Q38224605-809F2396-A20C-4089-B78B-78C139876A16 Q38673660-55A9E9D5-B247-4CBE-B54C-20C7EA9B95BE Q38816103-274379BE-21E8-4DD3-B752-1D5EA0CD7B18 Q39289115-FF3C2BEF-4102-4239-910C-94D76C340D07 Q41575544-05E7E936-6EAD-406C-98FC-899415BF8D72 Q41704997-9C75E3EE-6AE7-4CF4-824C-09BA0806E38E Q42183344-38EFBA64-176F-41C1-9D4B-23D7C68E22CE Q48226191-2EC8934C-CEDC-4F1E-964C-91C571E162C3 Q48726361-FAFBF226-67DE-4098-B2E3-0E0DE25447CF Q50933962-059A9EA0-BF31-47BA-B233-F5C691E8AB21 Q54309795-627CC4C9-95E7-4BD0-91F5-641E355AE471

P2860

Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progression

http://www.wikidata.org/entity/Q34077384

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Dissecting the expression of E ...... transformation and progression

@ast

Dissecting the expression of E ...... transformation and progression

@en

Dissecting the expression of E ...... transformation and progression

@nl

type

label

Dissecting the expression of E ...... transformation and progression

@ast

Dissecting the expression of E ...... transformation and progression

@en

Dissecting the expression of E ...... transformation and progression

@nl

prefLabel

Dissecting the expression of E ...... transformation and progression

@ast

Dissecting the expression of E ...... transformation and progression

@en

Dissecting the expression of E ...... transformation and progression

@nl

P1433

Q34077384-EF843741-63A7-45A6-AF2D-9482E514A67F

P1476

Q34077384-3FAFE8A1-44F7-4EA5-B1FC-7AA48DB25428

P2093

Q34077384-5BE81FE1-423B-482B-B97A-855D09477C24

Q34077384-6562DA1F-A8D2-4933-ACA5-3A84A3951AF0

Q34077384-B2B65EA7-6F0A-4179-81C7-21A4CBBCED8B

Q34077384-E606A5D9-5794-413E-AE3B-D0F24A918C97

Q34077384-EA2CE019-C26E-45A7-9964-0CD1956A4914

Q34077384-F304A175-ACA1-4566-A5C7-319572DE5BB7

P2860

Q34077384-123025DE-A12A-4965-AE31-9CEB423531D6

Q34077384-195025B2-5F32-4C55-AC0A-F1C235EAD637

Q34077384-1CB723A3-1D09-4FB9-9CFA-1E094C6B4092

Q34077384-1FCCC68A-45CC-4739-87D4-14C80C3D6A73

Q34077384-320A5E88-CD98-47A1-B93B-F895DD402CE2

Q34077384-41B3A6B6-A601-4ECF-8F6C-6E34F2880F3B

Q34077384-44463A09-13BF-4B1C-AFD1-BEA9CA0E9CF6

Q34077384-472AD9E0-0435-4593-B7C1-BDD347ACD7A4

Q34077384-4A351580-F7C0-43BF-848A-7CC9A79C7EF8

Q34077384-4F8A8687-5D7F-45DD-BC65-BB31B54634EC

P2888

Q34077384-C0FAADA4-ABBF-4719-877D-4C26799B307D

P304

Q34077384-2710B218-A6C6-4041-B81B-92BA444111F4

P31

Q34077384-4C21143A-2CC0-4D50-8A51-1359669FD8BD

P356

Q34077384-C8665C21-0D48-4507-909D-6885AE035C52

P407

Q34077384-233EF7ED-79D3-4943-904A-9F8617CF9359

P433

Q34077384-96004543-3692-459D-922D-784713087BF2

P478

Q34077384-56827812-B2B6-4D4A-BBAE-1BF78B1AEFDE

P50

Q34077384-310E0BC6-2E8F-4FE9-A038-D7AE53E1CD4D

Q34077384-8483562E-D37F-47A3-9F32-DAF814E862AA

Q34077384-BA825FA6-BE41-46D6-BCAD-B7C0182B3FC4

Q34077384-BEEB71B9-36BE-4D22-BF6E-C00518619B37

Q34077384-D24BE802-7711-49DA-8E74-CBA68CF5201E

P577

Q34077384-318E61F2-2873-4441-9FFD-4A19D3B00455

P5875

Q34077384-91A6E023-0B4B-4E6F-9B52-EA3DB978E494

P6179

Q34077384-5E3FB467-A781-43AF-8F6D-06C4A6DC97BB

P698

Q34077384-D92EED77-4D16-43C7-A76F-7C84CE6D628D

P932

Q34077384-7ABAED63-89C9-4150-8A0E-0209E6187CF3

P356

P1433

British Journal of Cancer

P1476

Dissecting the expression of E ...... transformation and progression

@en

P2093

B Dapas

http://www.w3.org/2001/XMLSchema#string

B Scaggiante

http://www.w3.org/2001/XMLSchema#string

C Giansante

http://www.w3.org/2001/XMLSchema#string

G Grassi

http://www.w3.org/2001/XMLSchema#string

M Grassi

http://www.w3.org/2001/XMLSchema#string

R Farra

http://www.w3.org/2001/XMLSchema#string

P2860

A2 isoform of mammalian translation factor eEF1A displays increased tyrosine phosphorylation and ability to interact with different signalling molecules

Tissue-dependent variation in the expression of elongation factor-1 alpha isoforms: isolation and characterisation of a cDNA encoding a novel variant of human elongation-factor 1 alpha

The development of androgen-independent prostate cancer

BPOZ-2 directly binds to eEF1A1 to promote eEF1A1 ubiquitylation and degradation and prevent translation.

Identification of different isoforms of eEF1A in the nuclear fraction of human T-lymphoblastic cancer cell line specifically binding to aptameric cytotoxic GT oligomers.

RNA quantitative analysis from fixed and paraffin-embedded tissues: membrane hybridization and capillary electrophoresis.

RNA extracted from paraffin-embedded human tissues is amenable to analysis by PCR amplification.

Tumor necrosis factor-alpha downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha 1

Androgen deprivation therapy for prostate cancer: current status and future prospects.

Cyclin E in normal and neoplastic cell cycles.

P2888

P304

166-173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2011.500

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

Fabrizio Zanconati

Salvatore Siracusano

P577

2011-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51807435

http://www.w3.org/2001/XMLSchema#string

P6179

1014343415

http://www.w3.org/2001/XMLSchema#string

P698

22095224

http://www.w3.org/2001/XMLSchema#string

P932

3251850

http://www.w3.org/2001/XMLSchema#string